UCMOK
PRPH

United Capital Management of KS’s ProPhase Labs PRPH Stock Holding History

United Capital Management of KS’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,470
Closed -$13.6K – 124
2025
Q2 		$13.6K Hold
3,470
– – ﹤0.01% 108
2025
Q1 		$14K Hold
3,470
– – ﹤0.01% 91
2024
Q4 		$26.3K Buy
+3,470
New +$48.7K ﹤0.01% 85

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

United Capital Management of KS's PRPH Position: Q3 2025 in Review

United Capital Management of KS sold out of ProPhase Labs (PRPH) in Q3 2025, closing a stake of 3,470 shares — an estimated $13.6K sold.

United Capital Management of KS first reported a position in PRPH in Q4 2024 and held it in 3 quarters. The position peaked at $26.3K in Q4 2024. 28 funds tracked by Wall St. Rank hold PRPH as of Q3 2025.

  • United Capital Management of KS reported no remaining ProPhase Labs position as of Q3 2025 after selling out during the quarter.
  • United Capital Management of KS sold 3,470 ProPhase Labs shares in Q3 2025, an estimated $13.6K.
  • United Capital Management of KS first reported a position in ProPhase Labs in Q4 2024 and held it in 3 quarters.
  • United Capital Management of KS's ProPhase Labs position peaked at $26.3K in Q4 2024.
  • 28 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2025.

Based on United Capital Management of KS's 13F filing for Q3 2025, filed 12 Nov 2025.